AG Rob Bonta announced a multistate settlement in principle with pharmaceutical company Mylan Inc. (Mylan) that will deliver up to $335 million nationwide to help combat the opioid crisis. Mylan, which is now a part of Viatris, has manufactured and sold a variety of opioids since 2005, including generic fentanyl patches, oxycodone, hydrocodone, and buprenorphine products. The attorneys general allege Mylan deceptively promoted its products as less prone to abuse despite knowing for years that many of its opioid products — particularly its fentanyl patches — were actually more vulnerable to abuse. The company fueled the opioid crisis by marketing directly to doctors, leading to dangerous overprescribing and diversion of its opioids into the illegal drug market. 

Attorney General Bonta Secures up to $335 Million from Pharmaceutical Company Mylan for Its Role in Fueling Opioid Crisis | State of California – Department of Justice – Office of the Attorney General